PCR & NGS Based Diagnostic Testing Market Size By Product (Consumables, Equipment, Labware), By End-use (Hospitals and Clinics, Diagnostic Centers, Ambulatory Settings), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: May 2021  |  Report ID: GMI5057  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 136   |   Base Year: 2020




Report Content

Chapter 1   Methodology

1.1    Methodology

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data Sources

1.5.1    Secondary

1.5.1.1    Paid Sources

1.5.1.2    Unpaid Sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    PCR & NGS based Diagnostic testing industry 3600 synopsis, 2016 – 2027

2.1.1    Business trends

2.1.2    Product trends

2.1.3    End-use trends

2.1.4    Regional trends

Chapter 3   PCR & NGS based Diagnostic Testing Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rising importance of diagnostic tests in virus detection

3.3.1.2    Growing usage of NGS technology by pharmaceutical and biopharmaceutical companies

3.3.1.3    Increasing research and developmental (R&D) activities in developed economies

3.3.1.4    High risk of infection in geriatric population

3.3.2    Industry pitfalls and challenges

3.3.2.1    High cost of diagnostic testing

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By end-use

3.5    COVID-19 impact analysis

3.5.1    Impact of COVID-19 on global PCR & NGS based diagnostic testing market

3.5.2    Impact of COVID-19 on industry value chain

3.5.2.1    Research and development

3.5.2.2    Manufacturing

3.5.2.3    Marketing

3.5.2.4    Supply

3.5.3    Impact of COVID-19 on industry competition

3.5.3.1    Strategy

3.5.3.2    Product portfolio

3.5.3.3    Business growth

3.6    Porter’s analysis

3.7    Competitive landscape, 2020

3.7.1    Company matrix analysis, 2020

3.7.2    Manufacturing scenario

3.7.2.1    List of equipment manufacturers in the U.S., Europe, and Asia

3.7.2.2    List of consumable manufacturers in the U.S., Europe, and Asia

3.8    Consumer dynamics: equipment purchase vs leasing

3.9    Supply chain analysis

3.10    PESTEL analysis

3.11    Technology roadmap and future trends

Chapter 4   PCR & NGS based Diagnostic Testing Market, By Product

4.1    Key segment trends

4.2    Consumables

4.2.1    Market size, by region, 2016 – 2027

4.3    Equipment

4.3.1    Market size, by region, 2016 – 2027

4.4    Labware

4.4.1    Market size, by region, 2016 – 2027

Chapter 5   PCR & NGS based Diagnostic Testing Market, By End-use

5.1    Key segment trends

5.2    Hospitals and clinics

5.2.1    Market size, by region, 2016 – 2027

5.3    Diagnostic centers

5.3.1    Market size, by region, 2016 – 2027

5.4    Ambulatory settings

5.4.1    Market size, by region, 2016 – 2027

5.5    Others

5.5.1    Market size, by region, 2016 – 2027

Chapter 6   PCR & NGS based Diagnostic Testing Market, By Region

6.1    Key regional trends

6.2    North America

6.2.1    Market size, by country, 2016 – 2027

6.2.2    Market size, by product, 2016 – 2027

6.2.3    Market size, by end-use, 2016 – 2027

6.2.4    U.S.

6.2.4.1    Market size, by product, 2016 – 2027

6.2.4.2    Market size, by end-use, 2016 – 2027

6.2.5    Canada

6.2.5.1    Market size, by product, 2016 – 2027

6.2.5.2    Market size, by end-use, 2016 – 2027

6.3    Europe

6.3.1    Market size, by country, 2016 – 2027

6.3.2    Market size, by product, 2016 – 2027

6.3.3    Market size, by end-use, 2016 – 2027

6.3.4    UK

6.3.4.1    Market size, by product, 2016 – 2027

6.3.4.2    Market size, by end-use, 2016 – 2027

6.3.5    France

6.3.5.1    Market size, by product, 2016 – 2027

6.3.5.2    Market size, by end-use, 2016 – 2027

6.3.6    Germany

6.3.6.1    Market size, by product, 2016 – 2027

6.3.6.2    Market size, by end-use, 2016 – 2027

6.3.7    Italy

6.3.7.1    Market size, by product, 2016 – 2027

6.3.7.2    Market size, by end-use, 2016 – 2027

6.3.8    Spain

6.3.8.1    Market size, by product, 2016 – 2027

6.3.8.2    Market size, by end-use, 2016 – 2027

6.4    Asia Pacific

6.4.1    Market size, by country, 2016 – 2027

6.4.2    Market size, by product, 2016 – 2027

6.4.3    Market size, by end-use, 2016 – 2027

6.4.4    India

6.4.4.1    Market size, by product, 2016 – 2027

6.4.4.2    Market size, by end-use, 2016 – 2027

6.4.5    China

6.4.5.1    Market size, by product, 2016 – 2027

6.4.5.2    Market size, by end-use, 2016 – 2027

6.4.6    Japan

6.4.6.1    Market size, by product, 2016 – 2027

6.4.6.2    Market size, by end-use, 2016 – 2027

6.4.7    Australia

6.4.7.1    Market size, by product, 2016 – 2027

6.4.7.2    Market size, by end-use, 2016 – 2027

6.5    Latin America

6.5.1    Market size, by country, 2016 – 2027

6.5.2    Market size, by product, 2016 – 2027

6.5.3    Market size, by end-use, 2016 – 2027

6.5.4    Brazil

6.5.4.1    Market size, by product, 2016 – 2027

6.5.4.2    Market size, by end-use, 2016 – 2027

6.5.5    Mexico

6.5.5.1    Market size, by product, 2016 – 2027

6.5.5.2    Market size, by end-use, 2016 – 2027

6.6    MEA

6.6.1    Market size, by country, 2016 – 2027

6.6.2    Market size, by product, 2016 – 2027

6.6.3    Market size, by end-use, 2016 – 2027

6.6.4    Saudi Arabia

6.6.4.1    Market size, by product, 2016 – 2027

6.6.4.2    Market size, by end-use, 2016 – 2027

6.6.5    South Africa

6.6.5.1    Market size, by product, 2016 – 2027

6.6.5.2    Market size, by end-use, 2016 – 2027

Chapter 7   Company Profiles

7.1    Strategy dashboard, 2020

7.2    Agilent Technologies, Inc

7.2.1    Business Overview

7.2.2    Financial data

7.2.3    Product landscape

7.2.4    Strategic outlook

7.2.5    SWOT analysis

7.3    Bio-Rad Laboratories, Inc

7.3.1    Business overview

7.3.2    Financial data

7.3.3    Product landscape

7.3.4    SWOT analysis

7.4    Eppendorf AG

7.4.1    Business Overview

7.4.2    Financial data

7.4.3    Product Landscape

7.4.4    SWOT analysis

7.5    Fluotics

7.5.1    Business overview

7.5.2    Financial data

7.5.3    Product landscape

7.5.4    SWOT analysis

7.6    Hamilton Company

7.6.1    Business overview

7.6.2    Financial data

7.6.3    Product landscape

7.6.4    Strategic outlook

7.6.5    SWOT analysis

7.7    Illumina, Inc

7.7.1    Business Overview

7.7.2    Financial data

7.7.3    Product landscape

7.7.4    SWOT analysis

7.8    Integra LifeScience Holdings Corporation

7.8.1    Business overview

7.8.2    Financial data

7.8.3    Product landscape

7.8.4    Strategic outlook

7.8.5    SWOT analysis

7.9    MGI Tech Co , Ltd

7.9.1    Business overview

7.9.2    Financial data

7.9.3    Product landscape

7.9.4    SWOT analysis

7.10    Mascon, Inc.

7.10.1    Business Overview

7.10.2    Financial data

7.10.3    Product Landscape

7.10.4    SWOT analysis

7.11    Qiagen

7.11.1    Business Overview

7.11.2    Financial data

7.11.3    Product Landscape

7.11.4    Strategy outlook

7.11.5    SWOT analysis

7.12    Roche Diagnostics

7.12.1    Business Overview

7.12.2    Financial data

7.12.3    Product Landscape

7.12.4    Strategy outlook

7.12.5    SWOT analysis

7.13    Thermo Fisher Scientific

7.13.1    Business Overview

7.13.2    Financial data

7.13.3    Product Landscape

7.13.4    Strategy outlook

7.13.5    SWOT analysis

7.14    Thomas Scientific (The Carlyle Group)

7.14.1    Business Overview

7.14.2    Financial data

7.14.3    Product Landscape

7.14.4    Strategy outlook

7.14.5    SWOT analysis

7.15    VWR International (Avantor, Inc.)

7.15.1    Business Overview

7.15.2    Financial data

7.15.3    Product Landscape

7.15.4    Strategy outlook

7.15.5    SWOT analysis
 

Data Tables

TABLE 1    Diagnostic testing market, 2016 - 2020, (USD Million)

TABLE 2    Diagnostic testing market, 2021 - 2027, (USD Million)

TABLE 3    Global PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 4    Global PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 5    Global PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 6    Global PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 7    Global PCR & NGS based diagnostic testing market by region, 2016 - 2020 (USD Million)

TABLE 8    Global PCR & NGS based diagnostic testing market by region, 2021 - 2027 (USD Million)

TABLE 9    Industry impact forces

TABLE 10    List of equipment manufacturers in US, Europe, and Asia

TABLE 11    List of consumable manufacturers in US, Europe, and Asia

TABLE 12    Consumables market by region, 2016 - 2020 (USD Million)

TABLE 13    Consumables market by region, 2021 - 2027 (USD Million)

TABLE 14    Equipment market by region, 2016 - 2020 (USD Million)

TABLE 15    Equipment market by region, 2021 - 2027 (USD Million)

TABLE 16    labware market by region, 2016 - 2020 (USD Million)

TABLE 17    Labware market by region, 2021 - 2027 (USD Million)

TABLE 18    Hospitals and clinics market by region, 2016 - 2020 (USD Million)

TABLE 19    Hospitals and clinics market by region, 2021 - 2027 (USD Million)

TABLE 20    Diagnostic centers market by region, 2016 - 2020 (USD Million)

TABLE 21    Diagnostic centers market by region, 2021 - 2027 (USD Million)

TABLE 22    Ambulatory settings market by region, 2016 - 2020 (USD Million)

TABLE 23    Ambulatory settings market by region, 2021 - 2027 (USD Million)

TABLE 24    Others market by region, 2016 - 2020 (USD Million)

TABLE 25    Others market by region, 2021 - 2027 (USD Million)

TABLE 26    North America PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)

TABLE 27    North America PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)

TABLE 28    North America PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 29    North America PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 30    North America PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 31    North America PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 32    U.S. PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 33    U.S. PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 34    U.S. PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 35    U.S. PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 36    Canada PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 37    Canada PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 38    Canada PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 39    Canada PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 40    Europe PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)

TABLE 41    Europe PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)

TABLE 42    Europe PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 43    Europe PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 44    Europe PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 45    Europe PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 46    UK PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 47    UK PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 48    UK PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 49    UK PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 50    France PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 51    France PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 52    France PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 53    France PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 54    Germany PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 55    Germany PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 56    Germany PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 57    Germany PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 58    Italy PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 59    Italy PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 60    Italy PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 61    Italy PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 62    Spain PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 63    Spain PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 64    Spain PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 65    Spain PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 66    Asia Pacific PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)

TABLE 67    Asia Pacific PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)

TABLE 68    Asia Pacific PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 69    Asia Pacific PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 70    Asia Pacific PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 71    Asia Pacific PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 72    India PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 73    India PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 74    India PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 75    India PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 76    China PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 77    China PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 78    China PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 79    China PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 80    Japan PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 81    Japan PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 82    Japan PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 83    Japan PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 84    Australia PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 85    Australia PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 86    Australia PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 87    Australia PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 88    Latin America PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)

TABLE 89    Latin America PCR & NGS based diagnostic testing market, by country, 2021 - 2027 USD Million)

TABLE 90    Latin America PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 91    Latin America PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 92    Latin America PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 93    Latin America PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 94    Brazil PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 95    Brazil PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 96    Brazil PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 97    Brazil PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 98    Mexico  PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 99    Mexico PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 100    Mexico  PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 101    Mexico  PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 102    MEA PCR & NGS based diagnostic testing market, by country, 2016 - 2020, (USD Million)

TABLE 103    MEA PCR & NGS based diagnostic testing market, by country, 2021 - 2027 (USD Million)

TABLE 104    MEA PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 105    MEA PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 106    MEA PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 107    MEA PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 108    Saudi Arabia PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 109    Saudi Arabia PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 110    Saudi Arabia PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 111    Saudi Arabia PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)

TABLE 112    South Africa PCR & NGS based diagnostic testing market, by product, 2016 - 2020, (USD Million)

TABLE 113    South Africa PCR & NGS based diagnostic testing market, by product, 2021 - 2027 (USD Million)

TABLE 114    South Africa PCR & NGS based diagnostic testing market, by end-use, 2016 - 2020, (USD Million)

TABLE 115    South Africa PCR & NGS based diagnostic testing market, by end-use, 2021 - 2027 (USD Million)
 

Charts & Figures

FIG. 1    Top-down approach

FIG. 2    COVID-19 detection kits data analysis approach

FIG. 3    Data validation

FIG. 4    PCR & NGS based Diagnostic testing industry 3600 synopsis, 2016 – 2027

FIG. 5    Industry segmentation

FIG. 6    Global PCR & NGS based diagnostic testing market, 2016 – 2027 (USD million)

FIG. 7    Growth potential analysis, by product

FIG. 8    Growth potential analysis, by end-use

FIG. 9    Impact of COVID-19 on PCR & NGS based diagnostic testing market, 2020-2022

FIG. 10  Impact of COVID-19 on industry value chain

FIG. 11  Impact of COVID-19 on industry competition

FIG. 12  Porter’s analysis

FIG. 13  Company matrix analysis, 2020

FIG. 14  Supply chain analysis

FIG. 15  PESTLE analysis

FIG. 16  Key segment trends, by product

FIG. 17  Key segment trends, by end-use

FIG. 18  Key regional trends

FIG. 19  Strategy dashboard, 2020
 

Premium Report Details

  • Published Date: May 2021
  • Pages: 136
  • Tables: 115
  • Charts / Figures: 19
  • Companies covered: 14
  • Countries covered: 15

Get a report that explains COVID-19 impact on this market

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X